ArticleEMBO molecular medicine2013

A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia.

Jiewen Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.